Sionna Therapeutics (SION) Interest & Investment Income (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Interest & Investment Income data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 6.0% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (up 30.65% YoY), and the FY2025 full-year result was $13.3 million, up 62.73% from the prior year.
• Interest & Investment Income slipped to $2.8 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.7 million in Q2 2025 to a low of $1.1 million in Q1 2024.
• A 3-year average of $2.7 million and a median of $2.8 million in 2026 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income surged 165.02% in 2025 and decreased 6.0% in 2026, its largest moves.
• Tracing SION's Interest & Investment Income over 3 years: stood at $2.1 million in 2024, then surged by 49.69% to $3.2 million in 2025, then fell by 11.1% to $2.8 million in 2026.
• Business Quant data shows SION's Interest & Investment Income at $2.8 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.